Materials science approaches in the development of broad-spectrum antiviral therapies
Source abstract
Abstract
The COVID-19 pandemic has reignited efforts to develop materials science innovations aimed at stopping viral infections. One of the greatest opportunities lies in developing broad-spectrum antiviral technologies that work against many viruses, which could be the key to thwarting outbreaks in the future.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: SARS-CoV-2 and COVID-19 Research · RNA Interference and Gene Delivery · Bacteriophages and microbial interactions
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (40)
Show source-provided references
1. Kelly, H. et al. PLoS ONE 6, e21828 (2011).10.1371/journal.pone.0021828 ↗
2. Coltart, C. E., Lindsey, B., Ghinai, I., Johnson, A. M. & Heymann, D. L. Philos. Trans. R. Soc. B 372, 20160297 (2017).10.1098/rstb.2016.0297 ↗
3. Ferguson, N. M. et al. Science 353, 353–354 (2016).10.1126/science.aag0219 ↗
4. Spiteri, G. et al. Eurosurveillance 25, 2000178 (2020).10.2807/1560-7917.ES.2020.25.9.2000178 ↗
5. Hoehl, S. et al. N. Engl. J. Med. 382, 1278–1280 (2020).10.1056/NEJMc2001899 ↗
6. Paules, C. I., Marston, H. D. & Fauci, A. S. JAMA 323, 707–708 (2020).10.1001/jama.2020.0757 ↗
7. Keener, A. Nat. Med. https://doi.org/10.1038/d41591-020-00002-4 (2020).10.1038/d41591-020-00002-4 ↗
8. Tetro, J. A. Microbes Infect. 22, 72–73 (2020).10.1016/j.micinf.2020.02.006 ↗
9. Mulangu, S. et al. N. Engl. J. Med. 381, 2293–2303 (2019).10.1056/NEJMoa1910993 ↗
10. Wang, M. et al. Cell Res. 30, 269–271 (2020).10.1038/s41422-020-0282-0 ↗
11. Kujawski, S. A. et al. Preprint at https://doi.org/10.1101/2020.03.09.20032896 (2020).10.1101/2020.03.09.20032896 ↗
12. Chen, Z. et al. Preprint at https://doi.org/10.1101/2020.03.22.20040758 (2020).10.1101/2020.03.22.20040758 ↗
13. Mahevas, M. et al. Preprint at https://doi.org/10.1101/2020.04.10.20060699 (2020).10.1101/2020.04.10.20060699 ↗
14. Tang, X. et al. Natl Sci. Rev. https://doi.org/10.1093/nsr/nwaa036 (2020).10.1093/nsr/nwaa036 ↗
15. Bennett, N. & Lemoine, G. J. Harv. Bus. Rev. https://hbr.org/2014/01/what-vuca-really-means-for-you (2014).
16. Nature 578, 191 (2020).10.1038/d41586-020-00379-9 ↗
17. Fauci, A. S. & Morens, D. M. N. Engl. J. Med. 374, 601–604 (2016).10.1056/NEJMp1600297 ↗
18. Wei, X., Li, X. & Cui, J. Natl Sci. Rev. 7, 239–242 (2020).10.1093/nsr/nwaa009 ↗
19. Bekerman, E. & Einav, S. Science 348, 282–283 (2015).10.1126/science.aaa3778 ↗
20. Broggi, A., Granucci, F. & Zanoni, I. J. Exp. Med. 217, e20190295 (2020).10.1084/jem.20190295 ↗
21. Lazear, H. M., Nice, T. J. & Diamond, M. S. Immunity 43, 15–28 (2015).10.1016/j.immuni.2015.07.001 ↗
22. Crotta, S. et al. PLoS Pathog 9, e1003773 (2013).10.1371/journal.ppat.1003773 ↗
23. De Clercq, E. Nat. Rev. Microbiol. 2, 704–720 (2004).10.1038/nrmicro975 ↗
24. Furuta, Y. et al. Antiviral Res. 100, 446–454 (2013).10.1016/j.antiviral.2013.09.015 ↗
25. Warren, T. K. et al. Nature 508, 402–405 (2014).10.1038/nature13027 ↗
26. De Clercq, E. Nat. Rev. Drug Discov. 6, 1001–1018 (2007).10.1038/nrd2424 ↗
27. Hangartner, L., Zinkernagel, R. M. & Hengartner, H. Nat. Rev. Immunol. 6, 231–243 (2006).10.1038/nri1783 ↗
28. Walker, L. M. & Burton, D. R. Nat. Rev. Immunol. 18, 297–308 (2018).10.1038/nri.2017.148 ↗
29. Cagno, V. et al. Nat. Mater. 17, 195–203 (2018).10.1038/nmat5053 ↗
30. Vigant, F., Santos, N. C. & Lee, B. Nat. Rev. Microbiol. 13, 426–437 (2015).10.1038/nrmicro3475 ↗
31. Jackman, J. A., Shi, P.-Y. & Cho, N.-J. ACS Infect. Dis. 5, 4–8 (2018).10.1021/acsinfecdis.8b00286 ↗
32. Vincent, M. R. S. et al. Proc. Natl Acad. Sci. USA 107, 17339–17344 (2010).10.1073/pnas.1010026107 ↗
33. Wolf, M. C. et al. Proc. Natl Acad. Sci. USA 107, 3157–3162 (2010).10.1073/pnas.0909587107 ↗
34. Jackman, J. A. et al. Nat. Mater. 17, 971–977 (2018).10.1038/s41563-018-0194-2 ↗
35. Speerstra, S. et al. Antiviral Res. 149, 164–173 (2018).10.1016/j.antiviral.2017.11.018 ↗
36. Bekerman, E. et al. J. Clin. Invest. 127, 1338–1352 (2017).10.1172/JCI89857 ↗
37. Schor, S. & Einav, S. DNA Cell Biol. 37, 63–69 (2018).10.1089/dna.2017.4033 ↗
38. Koh, C. et al. Lancet Infect. Dis. 15, 1167–1174 (2015).10.1016/S1473-3099(15)00074-2 ↗
39. Yurdaydin, C. et al. Hepatology 67, 1224–1236 (2018).10.1002/hep.29658 ↗
40. Cho, N.-J. et al. Gastroenterology 148, 616–625 (2015).10.1053/j.gastro.2014.11.043 ↗